Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Braveheart Bio, Inc. - Common Stock
(NQ:
BRVE
)
17.41
-2.69 (-13.38%)
Delayed Quote
Updated: 4:00 PM EST, Nov 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Braveheart Bio, Inc. - Common Stock
Braveheart Bio to Host Webinar – HCM Spotlight: Advancing a Next-Generation Cardiac Myosin Inhibitor – with Key Opinion Leader Discussion on November 6, 2026
October 30, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Braveheart Bio Announces Upcoming Presentations at the American Heart Association Scientific Sessions 2026
October 30, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Braveheart Bio to Participate in Stifel Cardiometabolic Forum
September 16, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
September 08, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Braveheart Bio to Participate in Cantor Global Healthcare Conference
September 01, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 07, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.